Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Favipiravir Is Associated With Reduced 28-Day Mortality in Severe Fever With Thrombocytopenia Syndrome: A Multicenter Propensity Score-Matched Study.

Journal of medical virology·2026
Same author

Analysis of the current situation of female induced abortion under China's "three-child policy".

PloS one·2026
Same author

Atomic-Scale Full-Size Engineering of Platinum Nanozymes Enables High-Efficiency Catalytic Therapy.

ACS nano·2026
Same author

Mediator subunit MED4 enforces metastatic dormancy in breast cancer.

Nature cell biology·2026
Same author

Electrochemical chlorination byproducts (ECBPs): A potential blind spot in electrochemical treatment of waste activated sludge.

Journal of hazardous materials·2026
Same author

An ORGANELLAR EXONUCLEASE is essential for nitric oxide dependent pollen tube growth responses.

Plant physiology and biochemistry : PPB·2026

Related Experiment Video

Updated: Jun 20, 2026

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.1K

Harnessing Organoid Platforms for Nanoparticle Drug Development.

Linanni Chen1,2,3,4, Xinying Luo1,2,3,4, Jiankang Zhang1,2,3,4

  • 1College of Science, Mathematics and Technology, Wenzhou-Kean University, Wenzhou, Zhejiang, People's Republic of China.

Drug Design, Development and Therapy
|July 23, 2025
PubMed
Summary

Tumor organoids offer a superior preclinical model for cancer nanomedicine by replicating human tumor complexity and the tumor microenvironment (TME). This approach enhances the reliability of nanodrug evaluation, accelerating clinical translation.

Keywords:
cancerdrug screeningnanoparticleorganoidpersonalized medicine

More Related Videos

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

1.9K
Author Spotlight: Advancing Organoid Generation for Drug Development Using iPSCs
06:38

Author Spotlight: Advancing Organoid Generation for Drug Development Using iPSCs

Published on: March 15, 2024

1.5K

Related Experiment Videos

Last Updated: Jun 20, 2026

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
12:41

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis

Published on: December 23, 2022

5.1K
Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

1.9K
Author Spotlight: Advancing Organoid Generation for Drug Development Using iPSCs
06:38

Author Spotlight: Advancing Organoid Generation for Drug Development Using iPSCs

Published on: March 15, 2024

1.5K

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Drug Delivery Systems

Background:

  • Clinical translation of cancer nanomedicine is limited by inadequate preclinical models.
  • Existing models fail to capture tumor microenvironment (TME) dynamics and patient variability.
  • This leads to unreliable predictions of nanodrug efficacy and safety.

Purpose of the Study:

  • To introduce tumor organoids as an advanced preclinical model for cancer nanomedicine.
  • To demonstrate the utility of organoids in evaluating nanodrug delivery, efficacy, and safety.
  • To highlight organoids' potential for personalized medicine and improved preclinical success rates.

Main Methods:

  • Development and utilization of three-dimensional tumor organoid cultures.
  • Characterization of organoids for architectural, molecular, and TME fidelity.
  • Application of organoids to assess nanodrug performance in pancreatic, breast, and glioblastoma cancer models.
  • Establishment of organoid biobanks for large-scale drug screening.

Main Results:

  • Tumor organoids accurately recapitulate native tumor architecture and TME interactions.
  • Organoids provide reliable assessments of nanodrug delivery efficiency and therapeutic effects.
  • Demonstrated efficacy in evaluating nanodrug safety profiles across diverse cancer types.
  • Organoid biobanks enable rapid screening and identification of tailored treatment strategies.

Conclusions:

  • Tumor organoids represent a significant advancement over conventional preclinical models in cancer nanomedicine.
  • The organoid-driven approach overcomes critical limitations in tumor modeling.
  • This paradigm accelerates the development and clinical translation of effective nanotherapies.